Arcus Biosciences Eulerpool Haberleri

Arcus Biosciences Hisse Haberleri

Arcus Biosciences, dünya çapında birçok gazeteci ve yatırımcı tarafından takip edilmektedir. En güncel Arcus Biosciences haberlerini burada bir araya getiriyoruz.

• 1 Haziran ·

  Yahoo
  Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
• 19 Mayıs ·

  SeekingAlpha
  Is TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To Fail
• 8 Mayıs ·

  Yahoo
  Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations
• 6 Mayıs ·

  SeekingAlpha
  Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call Transcript
• 23 Nisan ·

  Yahoo
  Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting
• 2 Nisan ·

  SeekingAlpha
  Arcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term Catalysts
• 21 Ocak ·

  Yahoo
  Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer
• 17 Ocak ·

  SeekingAlpha
  Undercovered Dozen: Lincoln National, Whitecap Resources, NMI Holdings, Healwell AI +
• 14 Ocak ·

  SeekingAlpha
  Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025
• 13 Ocak ·

  SeekingAlpha
  Arcus: Excellent Pipeline And Collaborations, Cash Runway